Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1Phase 1 1

Status

Unknown 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Conditions

Warts 4Torulopsis 1Condylomata Acuminata 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × PRA1 protein, Candida albicans × Clear all
NCT06749665 2024-12-27

Sclerotherapy and Candida Antigen in Treatment of Common Warts

Sohag University

Phase NA Not yet recruiting
75 enrolled

Warts

NCT04399577 2020-05-27

Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts

Zagazig University

Phase 2 Completed
39 enrolled

Warts

NCT03853785 2019-03-12

Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts

Assiut University

Phase 3 Unknown
45 enrolled

Condylomata Acuminata

NCT03158168 2018-07-24

Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts

Assiut University

Phase 3 Unknown
70 enrolled

Warts

NCT00569231 2011-01-25

Study With Candida Antigen for Treatment of Warts

University of Arkansas

Phase 1 Completed
18 enrolled 8 charts

Torulopsis, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡